Exosome Technologies Market

Q: What will be the CAGR of the global exosome technologies industry during the forecast period?

The CAGR is anticipated to be 18.2% from 2025 to 2035 Read More

Exosome Technologies Market (Product Type: Instruments, Kits and Reagents and Software/Services; Application: Diagnostics, Therapeutics, and Others; Therapeutic Area: Oncology, Neurodegenerative Disorders, Cardiology, Immunology and Inflammation, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Exosome Technologies Market Outlook

The global exosome technologies industry was valued at US$ 204.7 Mn in 2024
It is projected to grow at a CAGR of 18.2% from 2025 to 2035 and cross US$ 1.3 Bn by the end of 2035

Analysts’ Viewpoint regarding Exosome Technologies Market

The exosome technology market is increasingly being driven by rapid developments in molecular biology and biotechnology, especially in personalized medicine. Increased research expenditures coupled with new methods of isolation and purification, are leading to more efficient use of exosomes in research and clinical settings.

Exosome Technologies Market By Revenue

Regulatory bodies are also looking forward to develop standards for using exosome-based products, which further aligns with the exosome technologies.

The increasing interest in liquid biopsy-based applications is a considerable factor driving the exosome technologies market expansion. A liquid biopsy based on exosomes offers a real-time, non-invasive approach for monitoring disease progression and response of treatment in comparison with invasive tissue biopsy. This has significant potential benefits, particularly in the context of cancer, where early detection and continued monitoring can sizably affect patient management.

There is a rising interest in less invasive diagnostics, along with a growing number of R&D partnerships between academic institutions and biotech companies, which are accelerating the creation of exosome-based liquid biopsy platforms. These developments is poised to lead to widespread clinical utility for exosomes in different therapeutic contexts.

The exosome technologies market trends suggest increasing integration of bioengineering or nanotechnology principles with research dedicated to exosomes. New technologies are aimed at producing large amounts of exosomes, or manipulating surface properties of exosomes to enhance their therapeutic use and target specificity.

Synthetic exosome mimetics are being created as a more cost-effective solution for its research and clinical use. Moreover, increased emphasis has been laid on standardization of protocols for exosome characterization and quantitation to achieve reproducibility in clinical trials. Furthermore, collaborations between pharmaceutical and diagnostic companies are driving innovation with several pilot programs aimed at drug delivery systems involving exosomes.

Key innovations are the advancements of new exosome isolation kits, mass-producible production platforms, and increased-throughput analytical platforms for exosome profiling.

Market Introduction

Exosomes imply small extracellular vesicles released by cells and are essential for intercellular communication. They contain numerous bio-molecules (proteins, lipids, and nucleic acids) and have numerous possible diagnostic and therapeutic applications.

The exosome technologies constitute a range of products used for various stages of the exosome journey, including isolation kits, characterization kits, and detection kits that focus on the isolating, purifying, and analyzing exosomes. One of the positives associated with exosome technologies is that they have diagnostic as well as therapeutic potential for a broad spectrum of diseases including cardiovascular diseases, cancers, and neurological conditions.

Exosomes can be used as biomarkers for disease diagnosis as well as monitoring, and they can also be used as drug-delivery systems for various targeted therapies. However, there are also certain bottlenecks associated with the use of exosome technologies. For example, the heterogeneity of exosomes leads to complications in isolating as well as characterizing them. Moreover, the costs of exosome technologies and the lack of field standards do present a unique obstacle.

Exosome technologies include study, isolation, characterization, and therapeutic and diagnostic applications for exosomes; all for biomedical research and clinical applications. Size-exclusion chromatography, ultracentrifugation, and microfluidics are some of the advanced technologies that can be employed to extract and analyze exosomes from the biological fluids. Post isolation, exosomes could be analyzed for their molecular content, which could provide information regarding pathological and physiological processes in the subject being studied. Characterization techniques to analyze parameters such as size, structure, and composition of exosomes include flow cytometry, nanoparticle tracking analysis, and electron microscopy.

Attribute	Detail
Exosome Technologies Market Drivers	Rising Prevalence of Chronic Diseases Increasing Adoption of Exosome-Based Diagnostics in Clinical Settings
Exosome Technologies Market Drivers

Rising Prevalence of Chronic Diseases is Propelling the Exosome Technologies Market Share

Chronic diseases such as cardiovascular diseases, cancer, and neurological diseases are the major reasons for mortality and morbidity globally. Exosomes deliver varying biomolecules such as nucleic acids, proteins, and lipids, which are also probable targets for therapy and indicators for disease detection.

In recent years, the use of exosomes for diagnosing and treating chronic diseases has been a well-known research topic. Liquid biopsy based on exosomes has also been an emerging technology with great potential to diagnose and monitor cardiovascular diseases, cancer, and the other chronic diseases on a non-invasive level.

Exosomes can be engineered to administer therapeutic molecules such as siRNA, microRNA, and drugs to targeted cells, thereby creating a new frontier in chronic disease therapy.

The rising prevalence of chronic diseases is a major contributor to the growth of exosome technologies, which allow for early diagnosis, ongoing monitoring, and personalized treatment.

For example, as per the data published by WHO, non-communicable diseases (NCDs), or, chronic diseases comprising heart disease, cancer, stroke, diabetes and chronic lung disease, as a whole, are responsible for 74% of fatalities globally. Moreover, over three-quarters of all NCD deaths, and 86% of the 17 million individuals who died pre-maturely, or prior to reaching 70 years of age, belong to the low- and middle-income nations.

The epidemic of chronic diseases has devastating impacts the health of families and individuals and communities and is set to overwhelm the health systems. The socioeconomic impact of the diseases makes prevention and control of the diseases the most urgent priority for development.

Increasing Adoption of Exosome-Based Diagnostics in Clinical Settings is Fostering the Exosome Technologies Market Share

Increasing clinical use of exosome-based diagnostics is driving research and investment in exosome platforms. Clinicians are increasingly relying on liquid biopsies that examine tumor-derived exosomal biomarkers to diagnose non-invasive, highly sensitive, and specific diseases. The minimally invasive diagnosis leads to demand for robust technologies to isolate, detect and characterize exosomes.

As exosome-based assays become increasingly common in hospitals, there is a growing demand for point-of-care (POC) solutions. POC systems allow turnaround time to be shortened, workflow to be simplified, and delivery of diagnostic tests to lessen reliance upon central labs and their records. Developers are currently engineering novel microfluidic devices, immunoaffinity capture technologies and AI analytics, which can satisfy clinical demand for speed and precision.

Exosome technologies are also adopted by the clinicians performing clinical trials. As of mid-2023, 74 trials were assessing exosome-based diagnostic tests, demonstrating growing clinical validation, and acceptance. Similarly, regulatory clearances for exosome tests, such as Bio-Techne's ExoDx Prostate IntelliScore for prostate cancer, and Guardant's 360 CDx for non-small cell lung cancer demonstrate growing institutional confidence and adoption into clinical practice.

For instance, according to data published by National Library of Medicine (NLM), Exosome Diagnostics undertook an observational clinical trial on an efficacy study of the diagnostic test "ExoDx Prostate Intelliscore (EPI)". The observational trial included 532 participants with early clinical evidence of prostate cancer, including a cohort with high prostate-specific antigen levels that fell into a limit range of 2.0-10 ng/ml.

The participants were divided into two cohorts, where the first cohort were men who were already scheduled to have an initial prostate biopsy, and the second cohort comprised men who did not have a scheduled prostate biopsy. The aims of the study were to measure the performance of the urine test for the men in the first cohort and determine whether the urine test results could add or contribute to the decision-making process around whether to biopsy. The study concluded that, EPI was a non-invasive, straightforward, urine assay of gene expression, which had been validated on all the participants. The test significantly improved identification of patients with potentially more relevant disease and would ultimately lessen the overall number of inappropriate biopsies. Currently, ExoDx is the only exosome-based prostate cancer test that provides a unique data point to help with the prostate biopsy decision.

Kits and Reagents Leading Global Exosome Technologies Market

Exosome Technologies Market By Product Type

The kits and reagents segment leads the global exosome technologies market as kits and reagents are essential for isolating, purifying, and characterizing exosomes for both - research and clinical use, and such products are generally standardized, dependable, and simple to use, thereby making them time-efficient and reliably reproducible by the intended user.

Additionally, as diagnostics and therapeutics using exosomes are being used increasingly across biotechnology companies, laboratories, and clinical sites, high demand has emerged for quality kits and reagents. Kits and reagents are widely accepted in terms of assay sensitivity, adoption scalability, and friendly usability across a range of samples, leading to these products representing the most distinct offerings in the market.

Regional Outlook of Exosome Technologies Market

Exosome Technologies Market By Region

Attribute	Detail
Leading Region	North America

North America is the dominant region in the exosome technologies market due to the region’s strong infrastructure and funding, which is utilized for supporting biomedical innovation. Moreover, North America has a history of adoption of advanced diagnostics and therapeutics early in its application to clinical care.

The high level of awareness about exosome technologies among clinical care professionals further enhances this positive trajectory of an emerging area of application and innovation in clinical care. Collectively, the variety of factors fostering the development of exosome technologies is likely to solidify North America as the premier region in the pursuit of innovation and application of exosome technologies across several medical applications.

Analysis of Key Players in Exosome Technologies Market

The key market strategies pursued by the companies for contributing to exosome technologies market growth include engaging in strategic partnerships with research institutions, undertaking funding for clinical trials for validation, and expanding the product portfolios. The market players are also focusing on mergers and acquisitions, receiving approval from the regulators (e.g., FDA) , and the development of cost-effective and scalable technologies that can help market players reinforce their competitive market position and drive widespread usage at the global level.

ExoCan Healthcare Technologies Pvt Ltd, Capricor Therapeutics, Inc., Exocobio, Creative Biolabs, VivaZome Therapeutics Pty Ltd, EXO Biologics, Exosome Diagnostics GmbH, Coya Therapeutics, Inc., RION, Thermo Fisher Scientific, System Biosciences, LLC, AEGLE Therapeutics, Fujifilm Holding Corporation, Bio-Techne Corporation, and NOVIQ, are some of the leading players operating in the global exosome technologies market.

Each of these players has been profiled in the exosome technologies market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Exosome Technologies Market

In August 2025, Capricor Therapeutics announced that their subjects for the Phase 1 clinical trial were dosed to evaluate its StealthX exosome-based vaccine. The study is underwritten by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID), conducted under Project NextGen from the U.S. Department of Health and Human Services, and based on a review and clearance of an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). The trial was conducted by an NIAID funded network of clinical trial sites.
In April 2024, EXO Biologics, announced the successful acquisition of a total of up to EUR 16 Mn in Series A funding. EXO Biologics would use the proceeds to help fund the then ongoing and future clinical trials. It would also use this to support its continuing manufacturing expansion, including the improvement of its proprietary production platform, EXOPulse, and expand partnerships to enable pan-market access to both the platform and GMP Clinical grade exosomes for rapid access to clinical trials.

Exosome Technologies Market Snapshot

Attribute	Detail
Size in 2024	US$ 204.7 Mn
Forecast Value in 2035	US$ 1.3 Bn
CAGR	18.2%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Mn/Bn
Biotechnology Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Product Type Instruments Kits and Reagents Software/Services Application Emergency Services Liquid Biopsies Others (Biomarker Discovery, etc.) Therapeutics Drug Delivery Tissue Regeneration Vaccine Development Others (Gene Therapy, etc.) Others (Research, etc.) Therapeutic Area Oncology Neurodegenerative Disorders Cardiology Immunology and Inflammation Others (Respiratory disease, etc.) Source HEK293 cells Mesenchymal Stem Cell Platelet Erythrocyte NK cell-derived exosomes Others End-User Hospitals and Clinical Laboratories Pharmaceutical and Biotechnology Companies Others (Research Institute, etc.)
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China Australia India Japan South Korea ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	ExoCan Healthcare Technologies Pvt Ltd Capricor Therapeutics, Inc. Exocobio Creative Biolabs VivaZome Therapeutics Pty Ltd EXO Biologics Exosome Diagnostics GmbH Coya Therapeutics, Inc. RION Thermo Fisher Scientific System Biosciences, LLC AEGLE Therapeutics Fujifilm Holding Corporation Bio-Techne Corporation NOVIQ NITTA GELATIN INDIA LIMITED
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global exosome technologies market in 2024?

The global exosome technologies market was valued at US$ 204.7 Mn in 2024

How big will the global exosome technologies industry be in 2035?

The global exosome technologies industry is projected to reach more than US$ 1.3 Bn by the end of 2035

What are the factors driving the exosome technologies market?

The rising prevalence of chronic diseases, increasing adoption of exosome-based diagnostics in clinical settings, new rapid developments in biotechnology and molecular biology, and supportive regulatory frameworks and government funding for exosome research are some of the factors driving the expansion of exosome technologies market.

What will be the CAGR of the global exosome technologies industry during the forecast period?

The CAGR is anticipated to be 18.2% from 2025 to 2035

Who are the prominent players in the global exosome technologies market?

ExoCan Healthcare Technologies Pvt Ltd, Capricor Therapeutics, Inc., Exocobio, Creative Biolabs, VivaZome Therapeutics Pty Ltd, EXO Biologics, Exosome Diagnostics GmbH, Coya Therapeutics, Inc., RION, Thermo Fisher Scientific Inc., System Biosciences, LLC, AEGLE Therapeutics, Fujifilm Holding Corporation, Bio-Techne Corporation, and NOVIQ

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Exosome Technologies Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Exosome Technologies Market Analysis and Forecast, 2020 – 2035
  - Market Revenue Projections (US$ Mn)
Key Insights
- Regulatory Landscape across Key Regions/Countries
- PESTLE analysis
- Technological Advancement in Exosome Technology
- Overview On Exosome Cargo and Non Cargo Loading Services
- Properties of Exosomes
- Brand Analysis for Major Players Operating In Exosome Technology Market
- Exosome Technology Product/Service
- Merger and Acquisition Scenario
Global Exosome Technologies Market Analysis and Forecast, by Product Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Attractiveness Analysis, by Product Type
Global Exosome Technologies Market Analysis and Forecast, by Application
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Attractiveness Analysis, by Application
Global Exosome Technologies Market Analysis and Forecast, by Therapeutic Area
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Attractiveness Analysis, by Therapeutic Area
Global Exosome Technologies Market Analysis and Forecast, by Source
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Attractiveness Analysis, by Source
Global Exosome Technologies Market Analysis and Forecast, by End-user
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Attractiveness Analysis, by End-user
Global Exosome Technologies Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020 - 2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Exosome Technologies Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Value Forecast, by Country, 2020 - 2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Product Type
  - By Application
  - By Therapeutic Area
  - By Source
  - By End-user
  - By Country
Europe Exosome Technologies Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Product Type
  - By Application
  - By Therapeutic Area
  - By Source
  - By End-user
  - By Country/Sub-region
Asia Pacific Exosome Technologies Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Product Type
  - By Application
  - By Therapeutic Area
  - By Source
  - By End-user
  - By Country/Sub-region
Latin America Exosome Technologies Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Product Type
  - By Application
  - By Therapeutic Area
  - By Source
  - By End-user
  - By Country/Sub-region
Middle East & Africa Exosome Technologies Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Instruments
  - Kits and Reagent
  - Software/Services
- Market Value Forecast, by Application, 2020 - 2035
  - Diagnostics
    - Liquid Biopsies
    - Others
  - Therapeutic
    - Drug Delivery
    - Tissue Regeneration
    - Vaccine Development
    - Others
  - Others
- Market Value Forecast, by Therapeutic Area, 2020 - 2035
  - Oncology
  - Neurodegenerative Disorders
  - Cardiology
  - Immunology and Inflammation
  - Others
- Market Value Forecast, by Source, 2020 - 2035
  - HEK293 cells
  - Mesenchymal Stem Cell
  - Platelet
  - Erythrocyte
  - NK cell-derived exosomes
  - Others
- Market Value Forecast, by End-user, 2020 - 2035
  - Hospitals and Clinical Laboratories
  - Pharmaceutical and Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Product Type
  - By Application
  - By Therapeutic Area
  - By Source
  - By End-user
  - By Country/Sub-region
Competition Landscape
- Market Player – Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - ExoCan Healthcare Technologies Pvt. Ltd
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Capricor Therapeutics, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Exocobio
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - NOVIQ
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Creative Biolabs
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - VivaZome Therapeutics Pty Ltd
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - EXO Biologics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Exosome Diagnostics GmbH
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Coya Therapeutics, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - RION
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Thermo Fisher Scientific Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - System Biosciences, LLC
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - AEGLE Therapeutics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Fujifilm Holding Corporation
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bio-Techne Corporation
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 02: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 03: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
Table 04: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic, 2020 to 2035
Table 05: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 06: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 07: Global Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
Table 08: Global Exosome Technologies Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
Table 09: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Country, 2020-2035
Table 10: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 11: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 12: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
Table 13: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic, 2020 to 2035
Table 14: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 15: North America Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 16: North America Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
Table 17: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 18: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 19: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 20: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostic, 2020 to 2035
Table 21: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
Table 22: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 23: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 24: Europe Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
Table 25: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 26: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 27: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 28: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
Table 29: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic, 2020 to 2035
Table 30: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 31: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 32: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
Table 33: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 34: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 35: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 36: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
Table 37: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic, 2020 to 2035
Table 38: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 39: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 40: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
Table 41: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 42: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
Table 43: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
Table 44: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
Table 45: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic, 2020 to 2035
Table 46: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 to 2035
Table 47: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By Source, 2020 to 2035
Table 48: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: Global Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 02: Global Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 03: Global Exosome Technologies Market Revenue (US$ Mn), by Instruments, 2020 to 2035
Figure 04: Global Exosome Technologies Market Revenue (US$ Mn), by Kits and Reagent, 2020 to 2035
Figure 05: Global Exosome Technologies Market Revenue (US$ Mn), by Software/Services, 2020 to 2035
Figure 06: Global Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 07: Global Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 08: Global Exosome Technologies Market Revenue (US$ Mn), by Diagnostics, 2020 to 2035
Figure 09: Global Exosome Technologies Market Revenue (US$ Mn), by Therapeutic, 2020 to 2035
Figure 10: Global Exosome Technologies Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 11: Global Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 12: Global Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 13: Global Exosome Technologies Market Revenue (US$ Mn), by Oncology, 2020 to 2035
Figure 14: Global Exosome Technologies Market Revenue (US$ Mn), by Neurodegenerative Disorders, 2020 to 2035
Figure 15: Global Exosome Technologies Market Revenue (US$ Mn), by Cardiology, 2020 to 2035
Figure 16: Global Exosome Technologies Market Revenue (US$ Mn), by Immunology and Inflammation, 2020 to 2035
Figure 17: Global Exosome Technologies Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 18: Global Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 19: Global Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 20: Global Exosome Technologies Market Revenue (US$ Mn), by HEK293 cells, 2020 to 2035
Figure 21: Global Exosome Technologies Market Revenue (US$ Mn), by Mesenchymal Stem Cell, 2020 to 2035
Figure 22: Global Exosome Technologies Market Revenue (US$ Mn), by Platelet, 2020 to 2035
Figure 23: Global Exosome Technologies Market Revenue (US$ Mn), by Erythrocyte, 2020 to 2035
Figure 24: Global Exosome Technologies Market Revenue (US$ Mn), by NK cell-derived exosomes, 2020 to 2035
Figure 25: Global Exosome Technologies Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 26: Global Exosome Technologies Market Value Share Analysis, By End-User, 2024 and 2035
Figure 27: Global Exosome Technologies Market Attractiveness Analysis, By End-User, 2025–2035
Figure 28: Global Exosome Technologies Market Revenue (US$ Mn), by Hospitals and Clinical Laboratories, 2020 to 2035
Figure 29: Global Exosome Technologies Market Revenue (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020 to 2035
Figure 30: Global Exosome Technologies Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 31: Global Exosome Technologies Market Value Share Analysis, By Region, 2024 and 2035
Figure 32: Global Exosome Technologies Market Attractiveness Analysis, By Region, 2025–2035
Figure 33: North America Exosome Technologies Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 34: North America Exosome Technologies Market Value Share Analysis, by Country, 2024 and 2035
Figure 35: North America Exosome Technologies Market Attractiveness Analysis, by Country, 2025–2035
Figure 36: North America Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 37: North America Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 38: North America Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 39: North America Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 40: North America Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 41: North America Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 42: North America Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 43: North America Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 44: North America Exosome Technologies Market Value Share Analysis, By End-user, 2024 and 2035
Figure 45: North America Exosome Technologies Market Attractiveness Analysis, By End-user, 2025–2035
Figure 46: Europe Exosome Technologies Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 47: Europe Exosome Technologies Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 48: Europe Exosome Technologies Market Attractiveness Analysis, by Country / Sub-region, 2025–2035
Figure 49: Europe Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 50: Europe Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 51: Europe Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 52: Europe Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 53: Europe Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 54: Europe Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 55: Europe Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 56: Europe Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 57: Europe Exosome Technologies Market Value Share Analysis, By End-user, 2024 and 2035
Figure 58: Europe Exosome Technologies Market Attractiveness Analysis, By End-user, 2025–2035
Figure 59: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 60: Asia Pacific Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 61: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2025–2035
Figure 62: Asia Pacific Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 63: Asia Pacific Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 64: Asia Pacific Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 65: Asia Pacific Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 66: Asia Pacific Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 67: Asia Pacific Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 68: Asia Pacific Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 69: Asia Pacific Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 70: Asia Pacific Exosome Technologies Market Value Share Analysis, By End-user, 2024 and 2035
Figure 71: Asia Pacific Exosome Technologies Market Attractiveness Analysis, By End-user, 2025–2035
Figure 72: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 73: Latin America Exosome Technologies Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 74: Latin America Exosome Technologies Market Attractiveness Analysis, by Country / Sub-region, 2025–2035
Figure 75: Latin America Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 76: Latin America Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 77: Latin America Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 78: Latin America Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 79: Latin America Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 80: Latin America Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 81: Latin America Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 82: Latin America Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 83: Latin America Exosome Technologies Market Value Share Analysis, By End-user, 2024 and 2035
Figure 84: Latin America Exosome Technologies Market Attractiveness Analysis, By End-user, 2025–2035
Figure 85: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 86: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 87: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Country / Sub-region, 2025–2035
Figure 88: Middle East & Africa Exosome Technologies Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 89: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, By Product Type, 2025–2035
Figure 90: Middle East & Africa Exosome Technologies Market Value Share Analysis, By Application, 2024 and 2035
Figure 91: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, By Application, 2025–2035
Figure 92: Middle East & Africa Exosome Technologies Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 93: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, By Therapeutic Area, 2025–2035
Figure 94: Middle East & Africa Exosome Technologies Market Value Share Analysis, By Source, 2024 and 2035
Figure 95: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, By Source, 2025–2035
Figure 96: Middle East & Africa Exosome Technologies Market Value Share Analysis, By End-user, 2024 and 2035
Figure 97: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, By End-user, 2025–2035